JPWO2021107023A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021107023A5
JPWO2021107023A5 JP2021561498A JP2021561498A JPWO2021107023A5 JP WO2021107023 A5 JPWO2021107023 A5 JP WO2021107023A5 JP 2021561498 A JP2021561498 A JP 2021561498A JP 2021561498 A JP2021561498 A JP 2021561498A JP WO2021107023 A5 JPWO2021107023 A5 JP WO2021107023A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
same
substituted
different halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021561498A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021107023A1 (https=
JP7739180B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/044047 external-priority patent/WO2021107023A1/ja
Publication of JPWO2021107023A1 publication Critical patent/JPWO2021107023A1/ja
Publication of JPWO2021107023A5 publication Critical patent/JPWO2021107023A5/ja
Priority to JP2025145819A priority Critical patent/JP2025179148A/ja
Application granted granted Critical
Publication of JP7739180B2 publication Critical patent/JP7739180B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021561498A 2019-11-27 2020-11-26 シクロアルキルウレア誘導体 Active JP7739180B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025145819A JP2025179148A (ja) 2019-11-27 2025-09-03 シクロアルキルウレア誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019213860 2019-11-27
JP2019213860 2019-11-27
PCT/JP2020/044047 WO2021107023A1 (ja) 2019-11-27 2020-11-26 シクロアルキルウレア誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025145819A Division JP2025179148A (ja) 2019-11-27 2025-09-03 シクロアルキルウレア誘導体

Publications (3)

Publication Number Publication Date
JPWO2021107023A1 JPWO2021107023A1 (https=) 2021-06-03
JPWO2021107023A5 true JPWO2021107023A5 (https=) 2023-12-01
JP7739180B2 JP7739180B2 (ja) 2025-09-16

Family

ID=76129521

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021561498A Active JP7739180B2 (ja) 2019-11-27 2020-11-26 シクロアルキルウレア誘導体
JP2025145819A Pending JP2025179148A (ja) 2019-11-27 2025-09-03 シクロアルキルウレア誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025145819A Pending JP2025179148A (ja) 2019-11-27 2025-09-03 シクロアルキルウレア誘導体

Country Status (22)

Country Link
US (2) US12162872B2 (https=)
EP (1) EP4067344B1 (https=)
JP (2) JP7739180B2 (https=)
KR (1) KR20220106998A (https=)
CN (1) CN115003655B (https=)
AU (1) AU2020394131B2 (https=)
BR (1) BR112022009861A2 (https=)
CA (1) CA3157769A1 (https=)
CL (1) CL2022001389A1 (https=)
CR (1) CR20220310A (https=)
DK (1) DK4067344T3 (https=)
ES (1) ES3061443T3 (https=)
FI (1) FI4067344T3 (https=)
HR (1) HRP20251667T1 (https=)
IL (1) IL293387B2 (https=)
MX (1) MX2022006422A (https=)
PE (1) PE20221730A1 (https=)
PT (1) PT4067344T (https=)
SI (1) SI4067344T1 (https=)
TW (1) TWI869494B (https=)
WO (1) WO2021107023A1 (https=)
ZA (1) ZA202205444B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12503475B2 (en) 2020-09-03 2025-12-23 Centessa Pharmaceuticals (Uk) Limited Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
CN114014747B (zh) * 2021-08-30 2023-12-08 海南师范大学 一种多羟基环己烯类化合物及其制备方法与应用
CA3248959A1 (en) 2022-04-22 2025-02-03 Sumitomo Pharma Co., Ltd. BICYCLOAMINE CARBOXAMIDE DERIVATIVE
AR130709A1 (es) * 2022-10-07 2025-01-08 Kissei Pharmaceutical Compuesto de ciclopentano
WO2024095158A1 (en) 2022-10-31 2024-05-10 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists
TW202430169A (zh) 2022-12-16 2024-08-01 日商第一三共股份有限公司 2-氮雜雙環[3.1.1]庚烷化合物
JP2026501630A (ja) 2022-12-30 2026-01-16 エクソン、ラブズ、インコーポレイテッド ジヒドロ－キナゾリン、－ベンゾチアジンおよび－ベンズオキサジン誘導体ならびに神経疾患を治療または予防するためのオレキシン受容体作動薬としてのそれらの使用
WO2024168004A1 (en) * 2023-02-08 2024-08-15 Vertex Pharmaceuticals Incorporated Biaryl amide-containing agonists of orexin receptor type 2
TW202502342A (zh) 2023-06-02 2025-01-16 日商武田藥品工業股份有限公司 食慾素２受體促效劑用於改善睡眠期間之呼吸功能的用途
WO2025010314A1 (en) * 2023-07-05 2025-01-09 Vertex Pharmaceuticals Incorporated Urea-containing agonists of orexin receptor type 2
WO2025124698A1 (en) 2023-12-12 2025-06-19 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
TW202542165A (zh) 2023-12-19 2025-11-01 瑞士商愛杜西亞製藥有限公司 大環食慾素激動劑
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
AU2004231087B2 (en) 2003-04-15 2007-01-04 Merck Sharp & Dohme Corp. Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
KR20070015598A (ko) 2004-04-28 2007-02-05 다케다 야쿠힌 고교 가부시키가이샤 융합 퀴놀린 유도체 및 이의 용도
US20090111805A1 (en) 2005-02-24 2009-04-30 Pfizer Inc. Bicyclic heteroaromatic derivatives useful as anticancer agents
JP2010155827A (ja) * 2008-12-04 2010-07-15 Takeda Chem Ind Ltd スピロ環化合物
EP2604601B1 (en) 2010-08-10 2016-02-24 Astellas Pharma Inc. Hetero ring compound
GB201318222D0 (en) * 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
TW201627299A (zh) 2014-10-29 2016-08-01 美國禮來大藥廠 用於抑制微粒體前列腺素ｅ合成酶１之新穎羧酸化合物
EP3029024A1 (en) * 2014-12-02 2016-06-08 Ferrer Internacional, S.A. 2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
PL3411358T3 (pl) 2016-02-04 2022-02-28 Takeda Pharmaceutical Company Limited Podstawiony związek piperydynowy i jego zastosowanie
US20200207734A1 (en) 2017-08-03 2020-07-02 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof

Similar Documents

Publication Publication Date Title
JPWO2021107023A5 (https=)
JP2022548690A5 (https=)
RU2201927C2 (ru) Амидиновые соединения и фармацевтическая композиция, обладающая фактор ха ингибирующим действием
RU2395506C2 (ru) Антагонисты рецептора хемокина
JP2013516415A5 (https=)
RU2497813C2 (ru) 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение
RU2330019C2 (ru) Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и способ лечения хемокин-опосредованного болезненного состояния с их использованием
AU2005247746B2 (en) Cinnamide compound
RU2470918C2 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ОБЛАДАЮЩИЕ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ IκB КИНАЗЫ β
RU2368600C2 (ru) Производные дикетогидразина, фармацевтическая композиция, содержащая такие производные в качестве активного ингредиента, и их применение
KR102510858B1 (ko) 알파 v 인테그린 억제제로서의 아졸 아미드 및 아민
US20170266199A1 (en) Heterocyclic amides as rip1 kinase inhibitors as medicaments
JP2014532619A5 (https=)
RU2006138433A (ru) Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
JP2006500348A5 (https=)
RU2348628C2 (ru) Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
RU2002128614A (ru) Фармацевтически активные производные пиперидина, в частности в качестве модуляторов хемокин-рецепторной активности
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
CA2529443A1 (en) Pyrido[2,1-a]-isoquinoline derivatives as dpp-iv inhibitors
JP2008526723A5 (https=)
JP2000512645A (ja) スルホンアミド誘導体およびｃｎｓ障害の治療におけるそれらの使用
WO2003062233A1 (en) 2-acylaminothiazole derivative or salt thereof
JP2014506590A5 (https=)
RU2015116816A (ru) Производное имидазола
JP2005523901A5 (https=)